Literature DB >> 25220828

Enantioselective divergent syntheses of several polyhalogenated Plocamium monoterpenes and evaluation of their selectivity for solid tumors.

Carl V Vogel1, Halina Pietraszkiewicz, Omar M Sabry, William H Gerwick, Frederick A Valeriote, Christopher D Vanderwal.   

Abstract

The family of polyhalogenated monoterpenes from Plocamium counts over a hundred known members. Using glyceraldehyde acetonide as a chiral-pool precursor, an enantioselective and divergent strategy was developed that provides a blueprint for the synthesis of many of the small yet complex acyclic members of this family. The broad applicability of this approach is demonstrated with the short, eight-step synthesis of four natural products and three analogues. These syntheses are the first of any members of the acyclic polyhalogenated Plocamium monoterpenes and permitted the evaluation of their selectivity against a range of tumor cell lines.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antitumor agents; chlorination; olefination; stereocontrol; total synthesis

Mesh:

Substances:

Year:  2014        PMID: 25220828      PMCID: PMC4219742          DOI: 10.1002/anie.201407726

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  20 in total

1.  A Three-Step Synthesis of Halomon.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-10-02       Impact factor: 15.336

2.  Asymmetric total synthesis of danicalipin A and evaluation of biological activity.

Authors:  Taiki Umezawa; Masayuki Shibata; Kensuke Kaneko; Tatsufumi Okino; Fuyuhiko Matsuda
Journal:  Org Lett       Date:  2011-02-03       Impact factor: 6.005

3.  Asymmetric total synthesis of (+)-danicalipin A.

Authors:  Takehiko Yoshimitsu; Ryo Nakatani; Akihiro Kobayashi; Tetsuaki Tanaka
Journal:  Org Lett       Date:  2011-02-02       Impact factor: 6.005

4.  Synthesis of undecachlorosulfolipid A: re-evaluation of the nominal structure.

Authors:  Christian Nilewski; Nicholas R Deprez; Thomas C Fessard; Dong Bo Li; Roger W Geisser; Erick M Carreira
Journal:  Angew Chem Int Ed Engl       Date:  2011-07-08       Impact factor: 15.336

5.  Enantioselective dichlorination of allylic alcohols.

Authors:  K C Nicolaou; Nicholas L Simmons; Yongcheng Ying; Philipp M Heretsch; Jason S Chen
Journal:  J Am Chem Soc       Date:  2011-05-10       Impact factor: 15.419

6.  Total synthesis of a chlorosulpholipid cytotoxin associated with seafood poisoning.

Authors:  Christian Nilewski; Roger W Geisser; Erick M Carreira
Journal:  Nature       Date:  2009-01-29       Impact factor: 49.962

7.  Discovery and development of anticancer agents from marine sponges: perspectives based on a chemistry-experimental therapeutics collaborative program.

Authors:  Frederick A Valeriote; Karen Tenney; Joseph Media; Halina Pietraszkiewicz; Matthew Edelstein; Tyler A Johnson; Taro Amagata; Phillip Crews
Journal:  J Exp Ther Oncol       Date:  2012

8.  Stereoselective dichlorination of allylic alcohol derivatives to access key stereochemical arrays of the chlorosulfolipids.

Authors:  Grant M Shibuya; Jacob S Kanady; Christopher D Vanderwal
Journal:  J Am Chem Soc       Date:  2008-08-22       Impact factor: 15.419

9.  A pentahalogenated monoterpene from the red alga Portieria hornemannii produces a novel cytotoxicity profile against a diverse panel of human tumor cell lines.

Authors:  R W Fuller; J H Cardellina; Y Kato; L S Brinen; J Clardy; K M Snader; M R Boyd
Journal:  J Med Chem       Date:  1992-08-07       Impact factor: 7.446

10.  General approach to the synthesis of the chlorosulfolipids danicalipin A, mytilipin A, and malhamensilipin A in enantioenriched form.

Authors:  Won-jin Chung; Joseph S Carlson; Christopher D Vanderwal
Journal:  J Org Chem       Date:  2014-02-13       Impact factor: 4.354

View more
  8 in total

1.  Highly Selective Synthesis of Halomon, Plocamenone, and Isoplocamenone.

Authors:  Cyril Bucher; Richard M Deans; Noah Z Burns
Journal:  J Am Chem Soc       Date:  2015-09-29       Impact factor: 15.419

2.  Integrating Molecular Networking and Biological Assays To Target the Isolation of a Cytotoxic Cyclic Octapeptide, Samoamide A, from an American Samoan Marine Cyanobacterium.

Authors:  C Benjamin Naman; Ramandeep Rattan; Svetlana E Nikoulina; John Lee; Bailey W Miller; Nathan A Moss; Lorene Armstrong; Paul D Boudreau; Hosana M Debonsi; Frederick A Valeriote; Pieter C Dorrestein; William H Gerwick
Journal:  J Nat Prod       Date:  2017-01-05       Impact factor: 4.050

3.  Cytotoxic halogenated monoterpenes from Plocamium cartilagineum.

Authors:  Omar M M Sabry; Douglas E Goeger; Frederick A Valeriote; William H Gerwick
Journal:  Nat Prod Res       Date:  2016-09-14       Impact factor: 2.861

Review 4.  Stereoselective Halogenation in Natural Product Synthesis.

Authors:  Won-jin Chung; Christopher D Vanderwal
Journal:  Angew Chem Int Ed Engl       Date:  2016-02-02       Impact factor: 15.336

Review 5.  The Recurring Roles of Chlorine in Synthetic and Biological Studies of the Lissoclimides.

Authors:  Bonnie S Pak; Nantamon Supantanapong; Christopher D Vanderwal
Journal:  Acc Chem Res       Date:  2021-02-05       Impact factor: 22.384

6.  Selective bromochlorination of a homoallylic alcohol for the total synthesis of (-)-anverene.

Authors:  Frederick J Seidl; Noah Z Burns
Journal:  Beilstein J Org Chem       Date:  2016-07-01       Impact factor: 2.883

7.  Synthesis facilitates an understanding of the structural basis for translation inhibition by the lissoclimides.

Authors:  Zef A Könst; Anne R Szklarski; Simone Pellegrino; Sharon E Michalak; Mélanie Meyer; Camila Zanette; Regina Cencic; Sangkil Nam; Vamsee K Voora; David A Horne; Jerry Pelletier; David L Mobley; Gulnara Yusupova; Marat Yusupov; Christopher D Vanderwal
Journal:  Nat Chem       Date:  2017-07-03       Impact factor: 24.427

Review 8.  Seaweed Secondary Metabolites In Vitro and In Vivo Anticancer Activity.

Authors:  Djenisa H A Rocha; Ana M L Seca; Diana C G A Pinto
Journal:  Mar Drugs       Date:  2018-10-26       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.